Learn More
Medchemexpress LLC Norleual TFA | 99.9% | 888.97 | 1 MG

Supplier: Medchemexpress LLC HYP1415A1MG
Norleual TFA is an angiotensin (Ang) IV analog and a hepatocyte growth factor (HGF)/c-Met inhibitor with an IC50 of 3 pM. It acts as an AT4 receptor antagonist and demonstrates potent antiangiogenic activities. It significantly reduces HGF-dependent c-Met and Gab1 phosphorylation and attenuates HGF-dependent c-Met activation and downstream signaling. In vivo, Norleual TFA suppresses pulmonary colonization by B16-F10 murine melanoma cells.
- Reduces HGF-dependent c-Met and Gab1 phosphorylation
- Attenuates HGF-dependent c-Met activation and downstream signaling
- Inhibits HGF-dependent signaling, proliferation, migration, and invasion in multiple cell types
- Suppresses pulmonary colonization by B16-F10 murine melanoma cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.